BACKGROUND: The retroperitoneal approach and natural orifice specimen extraction surgery are emerging minimally invasive techniques in colorectal surgery. Each technique independently aims to reduce operative trauma and enhance postoperative recovery. This report presents the first known case combining these 2 minimally invasive strategies for the surgical treatment of rectosigmoid cancer. IMPACT OF INNOVATION: This combined approach has the potential to minimize both peritoneal and abdominal wall trauma. By performing key surgical steps (mobilization, devascularization, lymphadenectomy) through the retroperitoneal space and eliminating the need for an abdominal incision for specimen extraction, it may reduce postoperative pain and surgical site complications. TECHNOLOGY MATERIALS AND METHODS: A 68-year-old woman with rectosigmoid adenocarcinoma clinical stage T3N1M0 disease underwent the procedure. Trocar placement included a 10-millimeter umbilical port, three ports in the left flank for retroperitoneal access and an additional port for the transperitoneal phase of the procedure. Key steps performed retroperitoneally included sigmoid colon mobilization, D3 lymph node dissection, and vessel-sparing ligation of the inferior mesenteric artery (preserving the left colic artery) and inferior mesenteric vein. The retroperitoneal space was then connected to the abdominal cavity. The rectum was transected, and the specimen was extracted transrectally (natural orifice specimen extraction surgery type II). An end-to-end anastomosis was created with a circular stapler. PRELIMINARY RESULTS: The operation lasted 190 minutes with an estimated blood loss of 20 milliliters. The final histology confirmed a pathologic stage T3N1a adenocarcinoma with 1 positive lymph node out of 26 retrieved. There were no intraoperative or postoperative complications. The patient had an uneventful recovery and was discharged on postoperative day 7. CONCLUSION AND FUTURE DIRECTIONS: This approach represents a novel advancement in minimally invasive colorectal surgery, providing direct vascular access without entering the abdominal cavity and eliminating visible scars. It offers potential advantages for complex cases with adhesions or elevated body mass index and warrants further validation in larger prospective series. See New Technology Report Video.
Aim. Analysis of morphological changes in the mucous membrane of the gastrointestinal tract that developed against the background of COVID-19-associated pneumonia, accompanied by bleeding.Methods. The study included 72 cases of erosive and ulcerative gastroduodenal bleeding with complicated Covid-pneumonia. The patients were treated at the University Clinical Hospital No. 4 of Sechenov Moscow State Medical University (Sechenov University) from April 2020 to March 2022.Results. Morphological examination of biopsies from the gastrointestinal tract has provided irrefutable evidence of both direct and indirect effects of the SARS-CoV2 virus on cells of the gastrointestinal mucosa.Conclusion. The gastric mucosa in COVID-19 patients is exposed to the virus, which leads to erosive and ulcerative changes in it, leading to bleeding. This is simultaneously facilitated by anticoagulant and anti-inflammatory therapy given to such patients. These complications must be anticipated and prevented in a timely manner.
7 October 2026 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Background. COVID-19-associated coagulopathy is a major manifestation of severe SARS-CoV-2 infection and is characterized by hypercoagulability, endothelial dysfunction, marked systemic inflammation, and microvascular dysfunction. Despite extensive research on hemostatic abnormalities in COVID-19, the role of COVID-19-associated coagulopathy in gastroduodenal ulcerative lesions complicated by gastrointestinal ulceration and gastrointestinal bleeding remains poorly understood. Objective: To characterize COVID-19-associated coagulopathy in patients with gastroduodenal bleeding and determine the relationships between laboratory hemostatic parameters, the severity of lung involvement, hypoxemia, and the endoscopic characteristics of gastroduodenal ulceration. Material and methods. This retrospective study included 72 patients with COVID-19 pneumonia complicated by gastroduodenal bleeding. The analysis included parameters of primary and secondary hemostasis, markers of systemic inflammation, the extent of lung involvement on computed tomography, oxygen saturation, and the morphological characteristics of the ulcers. Correlation and logistic regression analyses were performed to identify factors associated with in-hospital mortality. Results. Patients exhibited pronounced COVID-19-associated coagulopathy, with elevated D-dimer and fibrinogen concentrations, increased C-reactive protein levels, and abnormalities of primary hemostasis. The extent of lung involvement and oxygen saturation were significantly associated with the morphological characteristics of the ulcers. Conclusion. In patients with gastroduodenal bleeding, COVID-19-associated coagulopathy is characterized by both hypercoagulability and hypocoagulability in the setting of pronounced systemic inflammation. The extent of gastroduodenal ulceration is associated not only with laboratory manifestations of coagulopathy but also with the severity of lung involvement, hypoxemia, thrombocytopenia, and ulcer morphometry.